High levels of community transmission and the co-circulation of respiratory viruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, respiratory syncytial virus (RSV) and others can increase pressure on healthcare systems.
Seasonal influenza activity is still widespread in the EU/EEA, with a slight increase in positivity in sentinel primary care starting from week 5/2023 related to increased type B virus circulation.
This issue of the Communicable Disease Threats Report (CDTR) covers the period 30 January - 5 February 2023 and includes updates on COVID-19, diphtheriae, mpox, influenza, influenza A (H9N2), influenza (H5N6), MERS-CoV, avian influenza, BSE, and Niaph virus.
Influenza activity had been decreasing across the Region since week 51/2022, with a slight increase in positivity in primary care sentinel observed in week 5/2023 related to type B virus circulation. Influenza intensity remains at moderate or high levels in many countries.
This issue of the Communicable Disease Threats Report (CDTR) covers the period 15-21 January 2023 and includes updates on COVID-19, diphtheriae, influenza, Mpox and Cholera.
As of week 48/2022, 24 737 detections had been reported. Of these detections, 93% were type A viruses, with A(H3N2) dominating (64%) over A(H1N1)pdm09 (36%), and 13% type B of which 321 were ascribed to a lineage, with all being B/Victoria.